Hester Biosciences Ltd (HESTERBIO) is currently trading at 2,182.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Hester Biosciences Limited is a leading animal healthcare company in India, specializing in poultry and large animal vaccines. Its strategic focus on biotechnology is highlighted by the recent approval of the H9N2 Avian Influenza vaccine, expanding its poultry vaccine portfolio. The company has successfully doubled its drug product capacity with the new fill/finish facility, supporting increased manufacturing capabilities. Hester's strategic shift aims to reduce dependence on tender-driven revenues, focusing on direct engagement with commercial markets. The company continues to invest in operational discipline, resulting in substantial improvements in profitability.

Over the past 52 weeks, Hester Biosciences Ltd has traded between a low of ₹1,250.95 and a high of ₹2,669.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Hester Biosciences Ltd has a market capitalization of approximately 1,859.94. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Hester Biosciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 13.58 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,859.94 Cr, Hester Biosciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Hester Biosciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Hester Biosciences Ltd is 13.58. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated net profit for Q1 FY27 was ₹97 crore, compared with ₹16.4 crore in Q1 FY26.